Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
Dytfeld, Dominik, Jasielec, Jagoda, Griffith, Kent A, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E, McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi, Jakubowiak, Andrzej J
Published in Haematologica (Roma) (01.09.2014)
Published in Haematologica (Roma) (01.09.2014)
Get full text
Journal Article
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
Jakubowiak, Andrzej J., Dytfeld, Dominik, Griffith, Kent A., Lebovic, Daniel, Vesole, David H., Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Nordgren, Brian, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E., McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi
Published in Blood (30.08.2012)
Published in Blood (30.08.2012)
Get full text
Journal Article
Identifying disturbance in archaeological sites in tropical northern Australia: Implications for previously proposed 65,000‐year continental occupation date
Williams, Martin A. J., Spooner, Nigel A., McDonnell, Kathryn, O'Connell, James F.
Published in Geoarchaeology (01.01.2021)
Published in Geoarchaeology (01.01.2021)
Get full text
Journal Article
Reply to “Letter to the editors on termite stone lines” by Smith et al. (2021)
Williams, Martin A. J., Spooner, Nigel A., McDonnell, Kathryn, O'Connell, James F.
Published in Geoarchaeology (01.07.2021)
Published in Geoarchaeology (01.07.2021)
Get full text
Journal Article
Final Results of Phase 1 MMRC Trial of Selinexor, Carfilzomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM)
Jakubowiak, Andrzej, Jasielec, Jagoda, Rosenbaum, Cara A., Cole, Craig E., Chari, Ajai, Nam, Jennifer, Severson, Erica, Stephens, Leonor A, McDonnell, Kathryn, Rosebeck, Shaun, Zimmerman, Todd, Karrison, Theodore, Zonder, Jeffrey
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone (KPd) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): A Multiple Myeloma Research Consortium multicenter study
Rosenbaum, Cara Ann, Stephens, Leonor Ano, Kukreti, Vishal, Zonder, Jeffrey A., Cole, Craig, Zimmerman, Todd M., Reece, Donna Ellen, Berdeja, Jesus G., Severson, Erica, Revethis, Andrea, Wolfe, Brittany, McDonnell, Kathryn, Nam, Jennifer, Griffith, Kent A., Jakubowiak, Andrzej J.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase 1b/2 Study of Carfilzomib, Pomalidomide, and Dexamethasone (KPd) in Patients (Pts) with Lenalidomide-Exposed and/or -Refractory but Proteasome Inhibitor (PI)-Naive or -Sensitive Multiple Myeloma: A Multiple Myeloma Research Consortium Multi-Center Study
Rosenbaum, Cara A., Kukreti, Vishal, Zonder, Jeffrey, Lebovic, Daniel, Zimmerman, Todd, Berdeja, Jesus G., McDonnell, Kathryn, Waite-Marin, Jessica, Griffith, Kent A., Jakubowiak, Andrzej
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Phase 1 MMRC Trial of Selinexor, Carfilzomib (CFZ), and Dexamethasone (DEX) in Relapsed and Relapsed/Refractory Multiple Myeloma (RRMM)
Jakubowiak, Andrzej, Jasielec, Jagoda, Rosenbaum, Cara A., Zonder, Jeffrey A, Cole, Craig E., Chari, Ajai, Nam, Jennifer, Stephens, Leonor A, McDonnell, Kathryn, Uribe, Rebecca, Rosebeck, Shaun, Rashal, Tami, Youssoufian, Hagop, Henry, Sarah, Shacham, Sharon, Kauffman, Michael, Zimmerman, Todd, Karrison, Theodore
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)
Zimmerman, Todd, Raje, Noopur S., Vij, Ravi, Reece, Donna, Berdeja, Jesus G., Stephens, Leonor A, McDonnell, Kathryn, Rosenbaum, Cara A., Jasielec, Jagoda, Richardson, Paul G, Gurbuxani, Sandeep, Nam, Jennifer, Severson, Erica, Wolfe, Brittany D., Rosebeck, Shaun, Stefka, Andrew, Dytfeld, Dominik, Griffith, Kent, Jakubowiak, Andrzej
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Letermovir Prophylaxis Outcomes in Allogeneic Hematopoietic Cell Transplant Recipients
Tollkuci, Eris, Yassa, Gizem, Kadanagowd, Anu, Baptista, Jacqueline, Hussain, Mohammad Junaid, Myers, Becca, Yun, Hyun Don, McDonnell, Kathryn A, Marinovic, Debra A, Varma, Ankur, Ziny, Sarah, Oginni, Mogboluwaga, Nathan, Sunita, Ustun, Celalettin
Published in Transplantation and cellular therapy (01.03.2021)
Published in Transplantation and cellular therapy (01.03.2021)
Get full text
Journal Article
Minimal Residual Disease Status Predicts Progression-Free Survival in Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated with Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (KRd)
Jasielec, Jagoda, Dytfeld, Dominik, Griffith, Kent A., McDonnell, Kathryn, Lebovic, Daniel, Kandarpa, Malathi, Anderson, Tara, Mietzel, Melissa, Faham, Malek, Lee, Liana, Levy, Joan, Alonge, Mattina, Rosebeck, Shaun, Kaminski, Mark, Jakubowiak, Andrzej
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Prognostic and Predictive Gene Expression Profiling (GEP) Markers Confirmed in Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Treated Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts)
van Vliet, Martin, Jasielec, Jagoda, Dytfeld, Dominik, Vij, Ravi, Dumee, Belinda, Bosman, Lizanne, deBest, Leonie C.M., Alonge, Mattina, Rosebeck, Shaun, Kandarpa, Malathi, McDonnell, Kathryn, Griffith, Kent A., van Beers, Erik H, Jakubowiak, Andrzej
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Phase II MMRC trial of extended treatment with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) plus autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM)
Zimmerman, Todd M., Griffith, Kent A., Jasielec, Jagoda, Rosenbaum, Cara Ann, McDonnell, Kathryn, Waite-Marin, Jessica, Berdeja, Jesus G., Raje, Noopur S., Reece, Donna Ellen, Vij, Ravi, Alonge, Mattina, Rosebeck, Shaun, Gurbuxani, Sandeep, Faham, Malek, Kong, Katherine A, Levy, Joan, Jakubowiak, Andrzej J.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Predictors Of Treatment Outcome With The Combination Of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) In Newly Diagnosed Multiple Myeloma (NDMM)
Jasielec, Jagoda, Dytfeld, Dominik, Griffith, Kent A., McDonnell, Kathryn, Lebovic, Daniel, Kandarpa, Malathi, Vesole, David H., Jagannath, Sundar, Mietzel, Melissa A., Vij, Ravi, Faham, Malek, Lee, Liana, van Beers, Erik H., van Vliet, Martin H., Levy, Joan, Alonge, Mattina, Rosebeck, Shaun, Kaminski, Mark S., Jakubowiak, Andrzej J.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up
Jakubowiak, Andrzej J., Dytfeld, Dominik, Griffith, Kent A., Jasielec, Jagoda, McDonnell, Kathryn, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Chottiner, Elaine G., Anderson, Tara B., Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra Z., Jobkar, Terri L., Durecki, Diane E., Mietzel, Melissa A, Couriel, Daniel R., Vij, Ravi, Kaminski, Mark Stefan
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
The Multiple Myeloma Research Consortium (MMRC): A Model For Accelerating Development Of Novel Therapies For Multiple Myeloma
Harrison, Beverly, Anderson, Kenneth C., Raje, Noopur, Richardson, Paul, Warren, Diane, Chari, Ajai, Jagannath, Sundar, La, Lisa, Berdeja, Jesus, Zimlich, Meredith, Fay, Joseph W., Powell, Sheila, Hofmeister, Craig C, Williams, Nita, Jakubowiak, Andrzej J., Zimmerman, Todd M., McDonnell, Kathryn, Krishnan, Amrita Y., Duarte, Lupe, Kumar, Shaji K, Birgin, Ann, Lonial, Sagar, Baron, Kenisha, Martin, Thomas, Wolf, Jeffrey L, Pelle-Day, Geraldine, Auerback, Glenna, Orloff, Gregory, Hodge, Nikki, Reece, Donna E, Trudel, Suzanne, Gul, Engin, Roy, Vivek, Maharaj, Michele, Siegel, David S., Aleman, Adolfo, Stewart, A. Keith, Hagerty, Rachel, Talpaz, Moshe, Collins, Roxane, Vij, Ravi, Fiala, Mark A., Zonder, Jeffrey, Pregja, Silva, Goldberg, Sharon, Levy, Joan, Dietz, Karen, Capone, Walter, Auclair, Daniel, Young, Anne Quinn, Giusti, Kathy
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article